Search

Select A Team:

About Us

UCI Anti-Cancer Challenge

October 05, 2024



UCI ANTI-CANCER CHALLENGE
Established in 2017, the UCI Anti-Cancer Challenge brings like-minded people together to fight cancer. Participants ride, run and walk to raise awareness and funds for promising research at the UCI Health Chao Family Comprehensive Cancer Center. Corporate partners underwrite event costs, ensuring that 100% of participant contributions go to promising pilot studies and early phase clinical trials. Since 2017, over 15,000 participants have registered to raise funds for cancer research, with thousands of friends and family members who support them on event day. This peer-to-peer challenge has raised more than $4.7 million for cancer research and consistently ranks among the Orange County Business Journal’s top five fundraising run/walks.


UCI HEALTH CHAO FAMILY COMPREHENSIVE CANCER CENTER
At the UCI Health Chao Family Comprehensive Cancer Center, we work to prevent, manage and cure cancer to help all people live healthier, longer lives. We are fighting cancer on all fronts with our basic science and clinical research. Our cancer center members — drawn from more than 32 departments and seven UC Irvine schools — are organized into three research areas: Biotechnology, Imaging & Drug Development; Systems, Pathways & Targets; and Cancer Control. These programs provide an interactive and collaborative infrastructure for cancer discovery, clinical investigations (including early phase and investigator-initiated trials) and population-based research.

As one of only 56 elite National Cancer Institute-designated comprehensive cancer centers in the nation, and the only one based in Orange County, we treat more patients with cancer — and more complex cases — than any other healthcare provider in our region.


UCI HEALTH
We are UCI Health: a devoted team of nationally regarded physicians, nurses, researchers, clinicians, educators and students united by a single calling — to improve the lives of the people in our community and beyond. As the only academic health system in Orange County, our multifaceted organization is dedicated to the discovery of new medical frontiers, to the teaching of future healers and to the delivery of the finest evidence-based care.

In 2022, UCI Health had over 10,000 new cancer-related patient visits. As UCI Health continues to expand, more people with cancer are gaining convenient access to the expert care provided by the UCI Health Chao Family Comprehensive Cancer Center.

Cancer services will also be offered at UCI Health — Irvine. Currently being built on the university’s north campus, this new medical complex will house a 144-bed hospital with an emergency department, the Joe C. Wen & Family Center for Advanced Care, and the Chao Family Comprehensive Cancer Center and Ambulatory Care building, which will offer the full range of cancer care. The new Irvine location will allow our cancer specialists to easily collaborate with campus partners to develop evidence-based, health and wellness practices, optimizing therapies and helping our patients join the ever-increasing ranks of Orange County cancer survivors.


CHILDREN'S HOSPITAL OF ORANGE COUNTY (CHOC)
CHOC, a pediatric healthcare system based in Orange County, California, is committed to being a leading destination for children’s health by providing exceptional and innovative care. Affiliated with the University of California, Irvine, CHOC's growing community includes two state-of-the-art hospitals in Orange and Mission Viejo and a regional network of primary and specialty care clinics serving children and families in four counties.  CHOC offers several clinical programs of excellence providing the highest levels of care for the most serious pediatric illnesses and injuries, physical and mental.  CHOC's research and innovation institutes are focused on translating real patient needs into real-world treatments so every child can live the heathiest and happiest life possible. A portion of the UCI Anti-Cancer Challenge proceeds are dedicated to pediatric cancer research.